This search looks for keywords in all of the website’s content. Search tips
Filter by
EventHumanAdvanced therapiesResearch and development
HumanAdvanced therapiesRegulatory and procedural guidanceResearch and developmentSME
During the 2020-23 COVID-19 public health emergency, the European Medicines Agency (EMA) provided guidance for medicine developers and pharmaceutical companies to help speed up development and approval for COVID-19 medicines and address regulatory challenges arising from the pandemic.
HumanCOVID-19Clinical trialsCompassionate useRegulatory and procedural guidanceMedicine shortagesResearch and developmentScientific advice
EventHumanAdvanced therapiesResearch and development
EventHumanAdvanced therapiesResearch and development
HumanCompassionate useEarly accessRegulatory and procedural guidanceResearch and development
EventHumanAdvanced therapiesResearch and development
EventHumanAdvanced therapiesEarly accessRegulatory and procedural guidanceInnovationMedicinesResearch and developmentScientific guidelines
HumanAdvanced therapiesRegulatory and procedural guidanceInnovationResearch and developmentScientific guidelines
HumanAdvanced therapiesRegulatory and procedural guidanceInnovationResearch and developmentScientific guidelines